Hirsch Anna
Institute of Ethics, History and Theory of Medicine, LMU Munich, Germany.
Med Health Care Philos. 2025 Jun;28(2):185-197. doi: 10.1007/s11019-024-10246-3. Epub 2025 Jan 10.
There are an increasing number of ways to enhance human abilities, characteristics, and performance. In recent years, the ethical debate on enhancement has focused mainly on the ethical evaluation of new enhancement technologies. Yet, the search for an adequate and shared understanding of enhancement has always remained an important part of the debate. It was initially undertaken with the intention of defining the ethical boundaries of enhancement, often by attempting to distinguish enhancements from medical treatments. One of the more recent approaches comes from Julian Savulescu, Anders Sandberg, and Guy Kahane. With their welfarist account, they define enhancement in terms of its contribution to individual well-being: as any state of a person that increases the chances of living a good life in the given set of circumstances. The account aims to contribute both to a shared and clear understanding of enhancement and to answering the question of whether we should enhance in certain ways or not. I will argue that it cannot live up to either claim, in particular because of its inherent normativity and its failure to adequately define well-being. Nevertheless, it can make a valuable contribution to an ethics of enhancement. As I will show, the welfarist account refocuses the debate on a central value in health care: well-being, which can be a relevant aspect in assessing the permissibility of biomedical interventions - especially against the background of new bioethical challenges. To fulfil this function, however, a more differentiated understanding of well-being is needed.
提升人类能力、特质和表现的方式越来越多。近年来,关于提升的伦理辩论主要集中在对新提升技术的伦理评估上。然而,寻求对提升的充分且共同的理解一直是辩论的重要组成部分。最初进行这项工作的目的是界定提升的伦理界限,通常是试图将提升与医学治疗区分开来。最近的一种方法来自朱利安·萨夫勒斯库、安德斯·桑德伯格和盖伊·卡哈内。基于他们的福利主义观点,他们根据提升对个人幸福的贡献来定义提升:即一个人在特定环境下增加过上美好生活机会的任何状态。该观点旨在既有助于对提升达成共同且清晰的理解,又有助于回答我们是否应以某些方式进行提升的问题。我将论证它无法实现这两个主张,特别是因为其固有的规范性以及未能充分界定幸福。然而,它可以为提升伦理做出有价值的贡献。正如我将表明的,福利主义观点将辩论重新聚焦于医疗保健中的一个核心价值:幸福,这在评估生物医学干预的可允许性时可能是一个相关方面——尤其是在新的生物伦理挑战背景下。然而,为了履行这一职能,需要对幸福有更细致的理解。